Drug Profile
VM 301
Alternative Names: OAS 1000; Pseudopterosin A methyl etherLatest Information Update: 27 Aug 2002
Price :
$50
*
At a glance
- Originator OsteoArthritis Sciences
- Developer Nexell Therapeutics [CEASED]; OsteoArthritis Sciences
- Class Antirheumatics; Nonsteroidal anti-inflammatories; Pseudopterosins
- Mechanism of Action Leukotriene B4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atopic dermatitis; Chronic wounds; Inflammation
Most Recent Events
- 14 Aug 2002 Discontinued - Phase-II for Chronic wounds in USA (Topical)
- 14 Aug 2002 Discontinued - Preclinical for Atopic dermatitis in USA (Topical)
- 14 Aug 2002 Discontinued - Preclinical for Inflammation in USA (Topical)